Macrophage Activation Syndrome–Associated Proteins and Enhanced Interferon‐γ Responsiveness in the Plasma Proteome of Patients With Multisystem Inflammatory Syndrome in Children in a Pretreatment Replication Single‐Center Cohort
We have validated several unique features of the plasma proteome of patients with MIS-C first identified in 2020. Discrepant TRIM21 expression in these two cohorts is due to anti-Ro52 autoantibodies in IVIg-treated patients. These data support the use of plasma cytokine profiling to rapidly diagnose MIS-C.
Authors
- Emily Yang
- Hamid Bassiri
- Cara Toland
- Audrey R. Odom John
- Edward M. Behrens
- Sarah McCuaig
- Paul J. Utz
- Katharine C. Konvinse
- Laura A. Vella
Institutions
- Johnson & Johnson (United States) (US)
- Children's Hospital of Philadelphia (US)
- Stanford Medicine (US)
- Institute of Infection and Immunity (CA)
- Stanford University (US)
Publication Details
- Journal
- ACR Open Rheumatology
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1002/acr2.70181
- Primary Topic
- Kawasaki Disease and Coronary Complications
- Type
- article
- Field-Weighted Citation Impact
- 0.00